Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term INHIBITION. Found 13 abstracts

Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, Blakely LJ, Eisenberg PD, Langer CJ, Blumenschein G, Johnson FM, Green S, Gualberto A. Phase II Study of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 2009 May;27(15):2516-22.   PMCID: not NIH funded
Pimkina J, Humbey O, Zilfou JT, Jarnik M, Murphy ME. ARF Induces Autophagy by Virtue of Interaction with Bcl-xl. Journal of Biological Chemistry. 2009 Jan;284(5):2803-10.   PMCID: PMC2631963
Aiyer HS, Vadhanam MV, Stoyanova R, Caprio GD, Clapper ML, Gupta RC. Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genes. International journal of molecular sciences. 2008 Mar;9(3):327-41.
Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study. Journal of Clinical Oncology. 2008 Oct;26(29):4708-13.
Lawrence SH, Jaffe EK. Expanding the concepts in protein structure-function relationships and enzyme kinetics: Teaching using morpheeins. Biochemistry and Molecular Biology Education. 2008 Jul;36(4):274-83.
Reinbold M, Luo JL, Nedelko T, Jerchow B, Murphy ME, Whibley C, Wei Q, Hollstein M. Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. Oncogene. 2008 Apr;27(19):2788-94.
Berencsi K, Meropol NJ, Hoffman JP, Sigurdson E, Giles L, Rani P, Somasundaram R, Zhang TQ, Kalabis J, Caputo L, Furth E, Swoboda R, Marincola F, Herlyn D. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture. Cancer Immunology Immunotherapy. 2007 Mar;56(3):359-70.
Eswaran J, Lee WH, Debreczeni JE, Filippakopoulos P, Turnbull A, Fedorov O, Deacon SW, Peterson JR, Knapp S. Crystal structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group IIPAKs. Structure (London, England : 1993). 2007 Feb;15(2):201-13.
Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang SY, Sun P, Narod SA. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiology Biomarkers & Prevention. 2007 May;16(5):912-6.
Lenzi R, Edwards R, June C, Seiden MV, Garcia ME, Rosenblum M, Freedman RS. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma. Journal of translational medicine. 2007 Dec;5:66.
Macias E, Kim Y, de Marval PL, Klein-Szanto A, Rodriguez-Puebla ML. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis. Cancer Research. 2007 Oct;67(20):9713-20.
Nordberg E, Friedman M, Gostring L, Adams GP, Brismar H, Nilsson FY, Stahl S, Glimelius B, Carlsson J. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nuclear Medicine and Biology. 2007 Aug;34(6):609-18.
Pandya KJ, Dahlberg S, Hidalgo M, Cohen RB, Lee MT, Schiller JH, Johnson DH. A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: A trial of the eastern cooperative oncology group (E1500). Journal of Thoracic Oncology. 2007 Nov;2(11):1036-41.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term INHIBITION

INHIBITION EXPRESSION MECHANISM PROTEIN PHOSPHORYLATION CARCINOMA GENE DOMAIN TUMORIGENESIS mutation hotspot lung cancer-embryonic broblasts-senescence-polymorphism chemotaxis ACTIVATION LOOP REGRESSION POSTMENOPAUSAL WOMEN COMPLEX METASTASIS BEVACIZUMAB P19(ARF) TUMOR-SUPPRESSOR LUNG-CANCER MICE DEFICIENT allosteric regulation THERAPY P53-INDEPENDENT APOPTOSIS HIV-1 TRANSVERSIONS FIBROBLAST INTERACTIONS internalization CCI-779 TUMOR-DEVELOPMENT CATECHOL ESTROGENS CAPILLARIES GROWTH-FACTOR BIOLOGY CANCER PATIENTS MTOR POLYMORPHISMS ADDUCTS dietary intervention A431 CYCLIN-DEPENDENT KINASE-4 P-32-postlabeling BECLIN-1 MOUSE SKIN CARCINOGENESIS ANGIOGENESIS ERBB RECEPTORS MODEL FORMS MITOCHONDRIAL P-32 temsirolimus INSULIN-RECEPTOR ACTIVATION RESISTANCE STATISTICS CAFFEINE CHEMOPREVENTIVE AGENTS PLASMA-LEVELS P27(KIP1) ellagic acid GENE-MUTATIONS EGFR IN-VIVO PLASMA receptors new course development DEPENDENT PROTEIN-KINASE retention C-MYC 4-Hydroxy estradiol polyphenols VIRUSES DYNAMICS POPULATION radionuclide apoptosis MALIGNANCIES MURINE FIBROBLASTS TUMOR-GROWTH ANTIOXIDANT POLYMORPHIC VARIANTS MAP KINASE PREMENOPAUSAL phase II study P53 TRIAL CHEMOTHERAPY-NAIVE PATIENTS GROWTH-FACTOR VEGF CULTURED RAT DENDRITIC CELLS action mechanism CTL COLLAGEN MATRIX TEA PRINCIPLES RAPAMYCIN CELL-CYCLE IGF HYDROGEN-PEROXIDE tumor immunity metabolic pathways and CANCER CELL-LINES GROWTH-FACTOR RECEPTOR protein COMPARING CISPLATIN regulation QUATERNARY STRUCTURE ISOFORMS small-cell lung cancer ADDUCTION DNA-DAMAGE affibody molecule SRC TYROSINE KINASE edible raspberries HUMAN PORPHOBILINOGEN SYNTHASE INTERFERON enzymes and catalysis structure function and berries chemokines CANCER HETERODIMERIZATION RAT ESOPHAGUS TUMORS DNA damage and repair curriculum development INTEGRASE protein structure function and folding HOTSPOTS ESTRADIOL CXC-CHEMOKINE HOT-SPOTS
Last updated on Saturday, July 04, 2020